Kate Jeffrey

Company: Moderna

Job title: Vice President - Immune Therapeutics Discovery

Seminars:

Harnessing mRNA-encoded Cytokines as Immune Therapeutics for a Focused Immune Response 4:30 pm

Engineered cytokines encoded by nucleoside modified mRNA and delivered in LNPs enables tailored and focused immune therapeutics Multiplexing a myriad of cytokines by the mRNA/LNP platform allows next-generation broad immunomodulation for clinical benefit Providing examples of harnessing mRNA technology for manipulating the immune response via cytokines for autoimmune and inflammatory diseaseRead more

day: Conference Day One